Page last updated: 2024-09-03

ly 274614 and midazolam

ly 274614 has been researched along with midazolam in 1 studies

Compound Research Comparison

Studies
(ly 274614)
Trials
(ly 274614)
Recent Studies (post-2010)
(ly 274614)
Studies
(midazolam)
Trials
(midazolam)
Recent Studies (post-2010) (midazolam)
960159,8343,1913,301

Protein Interaction Comparison

ProteinTaxonomyly 274614 (IC50)midazolam (IC50)
Cytochrome P450 3A4Homo sapiens (human)2.7427

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartlett, SE; Cramond, T; Smith, MT1

Other Studies

1 other study(ies) available for ly 274614 and midazolam

ArticleYear
The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.
    Life sciences, 1994, Volume: 54, Issue:10

    Topics: Akathisia, Drug-Induced; Animals; Behavior, Animal; Binding Sites; Dose-Response Relationship, Drug; Injections, Intraventricular; Isoquinolines; Male; Midazolam; Morphine Derivatives; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Specific Pathogen-Free Organisms

1994